[HTML][HTML] Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: communication from the ISTH …

A Vandevelde, W Chayoua, B de Laat, JC Gris… - Journal of Thrombosis …, 2022 - Elsevier
Background Antiβ2glycoprotein I (aβ2GPI) and anticardiolipin (aCL) IgG/IgM show
differences in positive/negative agreement and titers between solid phase platforms. Method …

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC …

A Vandevelde, W Chayoua… - Journal of …, 2022 - cris.maastrichtuniversity.nl
Background Anti beta 2glycoprotein I (a beta 2GPI) and anticardiolipin (aCL) IgG/IgM show
differences in positive/negative agreement and titers between solid phase platforms. Method …

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: communication from the ISTH SSC …

A Vandevelde, W Chayoua, B de Laat… - JOURNAL OF …, 2022 - biblio.ugent.be
Background Anti beta 2glycoprotein I (a beta 2GPI) and anticardiolipin (aCL) IgG/IgM show
differences in positive/negative agreement and titers between solid phase platforms. Method …

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC …

A Vandevelde, W Chayoua, B de Laat, JC Gris… - Journal of Thrombosis …, 2022 - hal.science
Antiβ2glycoprotein I (aβ2GPI) and anticardiolipin (aCL) IgG/IgM show differences in
positive/negative agreement and titers between solid phase platforms. Method-specific …

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: communication from the ISTH SSC …

A Vandevelde, W Chayoua, B de Laat, J Gris… - Journal of Thrombosis … - repository.mdx.ac.uk
Background Antiβ2glycoprotein I (aβ2GPI) and anticardiolipin (aCL) IgG/IgM show
differences in positive/negative agreement and titers between solid phase platforms. Method …

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC …

A Vandevelde, W Chayoua, B de Laat… - … of Thrombosis and …, 2021 - europepmc.org
Background Antiβ2glycoprotein I (aβ2GPI) and anticardiolipin (aCL) IgG/IgM show
differences in positive/negative agreement and titers between solid phase platforms. Method …

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC …

A Vandevelde, W Chayoua… - … of thrombosis and …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Antiβ2glycoprotein I (aβ2GPI) and anticardiolipin (aCL) IgG/IgM show
differences in positive/negative agreement and titers between solid phase platforms. Method …

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC …

A Vandevelde, W Chayoua, B de Laat… - … of Thrombosis and …, 2022 - Wiley Online Library
Background Antiβ2glycoprotein I (aβ2GPI) and anticardiolipin (aCL) IgG/IgM show
differences in positive/negative agreement and titers between solid phase platforms. Method …